EP4079850 - ANALYTICAL METHOD AND KIT [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.09.2022 Database last updated on 22.08.2024 | |
Former | The international publication has been made Status updated on 25.06.2021 | Most recent event Tooltip | 24.07.2024 | The date on which the examining division becomes responsible, has been established | 24.07.2024 | Amendment by applicant | Applicant(s) | For all designated states KABUSHIKI KAISHA TOSHIBA 1-1, Shibaura 1-chome Minato-ku Tokyo 105-0023 / JP | [2022/43] | Inventor(s) | 01 /
INADA, Mika c/o Toshiba Corp. (K. K. TOSHIBA), 1-1, Shibaura 1-chome, Minato-ku Tokyo 105-0023 / JP | 02 /
HASHIMOTO, Koji c/o Toshiba Corp. (K. K. TOSHIBA), 1-1, Shibaura 1-chome, Minato-ku Tokyo 105-0023 / JP | [2022/43] | Representative(s) | Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB | [2022/43] | Application number, filing date | 20900777.2 | 11.12.2020 | [2022/43] | WO2020JP46391 | Priority number, date | WO2019JP49450 | 17.12.2019 Original published format: PCT/JP2019/049450 | [2022/43] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021125105 | Date: | 24.06.2021 | Language: | JA | [2021/25] | Type: | A1 Application with search report | No.: | EP4079850 | Date: | 26.10.2022 | Language: | EN | [2022/43] | Search report(s) | International search report - published on: | JP | 24.06.2021 | (Supplementary) European search report - dispatched on: | EP | 03.01.2024 | Classification | IPC: | C12N15/09, C12Q1/68 | [2022/43] | CPC: |
C12Q1/6886 (EP,CN,US);
C12N15/09 (EP);
C12Q2600/118 (EP);
C12Q2600/158 (EP,CN);
C12Q2600/178 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/43] | Title | German: | ANALYTISCHES VERFAHREN UND KIT | [2022/43] | English: | ANALYTICAL METHOD AND KIT | [2022/43] | French: | MÉTHODE ET KIT ANALYTIQUES | [2022/43] | Entry into regional phase | 10.09.2021 | Translation filed | 10.09.2021 | National basic fee paid | 10.09.2021 | Search fee paid | 10.09.2021 | Designation fee(s) paid | 10.09.2021 | Examination fee paid | Examination procedure | 10.09.2021 | Examination requested [2022/43] | 23.07.2024 | Amendment by applicant (claims and/or description) | 23.07.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 13.10.2022 | Renewal fee patent year 03 | 15.11.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - SALAZAR-RUALES CAROLINA ET AL, "Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population", BIOMED RESEARCH INTERNATIONAL, vol. 2018, doi:10.1155/2018/9792730, ISSN 2314-6133, (20181121), pages 1 - 9, URL: http://downloads.hindawi.com/journals/bmri/2018/9792730.xml, XP093110477 [A] 1-30 * the whole document * DOI: http://dx.doi.org/10.1155/2018/9792730 | International search | [XYA]US2012309645 (KELLER ANDREAS [DE], et al) [X] 1-8, 12-18, 22-30 * claims * [Y] 11, 21 [A] 9-10, 19-20; | [XYA]US2013196869 (QU KEVIN [US], et al) [X] 1-4, 13-16, 22,24, 26-28, 30 * claims, table 9 * [Y] 11, 21 [A] 5-10, 12, 17-20, 23, 25, 29; | [XYA]US2014308674 (HAO HONGYING [US], et al) [X] 1-4, 13-16, 22,24, 26-28, 30 * claims, tables A, 6 * [Y] 11, 21 [A] 5-10, 12, 17-20, 23, 25, 29; | [Y]JP2015039365 (TORAY INDUSTRIES, et al) [Y] 11, 21* examples *; | [Y]JP2015051011 (NEC CORP, et al) [Y] 9, 11-14, 19,21 * claims *; | [Y]WO2015133477 (UNIV HIROSHIMA [JP]) [Y] 10-14, 20, 21 * claims *; | [Y]WO2015190584 (TORAY INDUSTRIES [JP], et al) [Y] 9, 11-14, 19,21 * claims, table 7 *; | [Y]JP2016178921 (GENOMIC HEALTH INC) [Y] 9, 11-14, 19,21 * claims, table 90 *; | [XYA] - ZHANG, Z. et al., "Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data", Cellular Physiology and Biochemistry, (20180830), vol. 49, no. 2, pages 678 - 695, XP055836148 [X] 1-2, 4-8, 12- 18, 22-30 * , abstract, table 2, discussion * [Y] 10-14, 20-21 [A] 3, 9, 19 DOI: http://dx.doi.org/10.1159/000493033 | [XYA] - SONG, XIANLU et al., "miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and CSK3beta", Biomedicine & Pharmacotherapy, (20180300), vol. 99, pages 369 - 374, XP055836149 [X] 1-8, 12-18,22-30 * , abstract, page 370, right column, lines 14-26 * [Y] 9, 11-14, 19,21 [A] 10, 20 | [XYA] - WANG, L. et al., "Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer", JBUON, (20190501), vol. 24, no. 3, pages 1120 - 1127, XP055836139 [X] 1-8, 12-18, 22-30 * , summary, fig. 3, 4 * [Y] 11, 21 [A] 9-10, 19-20 | [XYA] - WU, Q. et al., "EZH2 induces the expression of miR- 1301 as a negative feedback control mechanism in triple negative breast cancer", Acta Biochim Biophys Sin, (20180701), vol. 50, no. 7, pages 693 - 700, XP055836142 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, fig. 1 * [Y] 11, 21 [A] 3, 9-10, 19-20 DOI: http://dx.doi.org/10.1093/abbs/gmy050 | [XYA] - LIANC, L. et al., "Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation", MOLECULAR MEDICINE REPORTS, (20180100), vol. 17, no. 1, pages 939 - 951, XP055836144 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, table II, fig. 1 * [Y] 10-14, 20-21 [A] 3, 9, 19 DOI: http://dx.doi.org/10.3892/mmr.2017.7945 | [XYA] - FANC, L. et al., "microRNA-1301-mediated inhibition of tumorigenesis", ONCOLOCY REPORTS, (20120400), vol. 27, no. 4, pages 929 - 934, XP055836145 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, introduction * [Y] 10-14, 20-21 [A] 3, 9, 19 DOI: http://dx.doi.org/10.3892/or.2011.1589 |